← Leaderboards
David C Musch
University Of Michigan At Ann Arbor
$2,966,828
Attributed
$3,297,953
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $434.2K · FY2005–22$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,297,953 · 8
By mechanism
R21$2,148,557 · 5
R03$459,000 · 1
D43$457,146 · 1
R34$233,250 · 1
Top collaborators
- Sayoko E Moroi2 shared
- Joshua D Stein1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Maryfran R Sowers$31,711,856
- Sung Kyun Park$9,220,850
- Natela M. Shanidze$3,396,401
- Marc A Zimmerman$59,887,623
- Kristin Tomey$613,734
Others in their field
Top investigators on “Vision”
- Chanza Baytop · Westat, Inc.$271,217,917
- Edward W Maly · United Nations Children'S Fund$264,005,699
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Everette D Joseph · Howard University$243,972,016
Research focus
VisionReportingGlaucomaVisual FieldsBaseVisual ImpairmentMedicalNational Eye InstituteClinical TrialsData AnalysesApplications GrantsResearch PersonnelNewly DiagnosedOpen-Angle GlaucomaInsightRisk FactorsEye DiseasesVisualMonitorAffectCharacteristicsClinically RelevantBlindnessClinical Research
Grant awards (15)
Building Non-Communicable Eye Disease Research Capacity in India$223,594
D43 · FY2022 · TW · contact PI
Building Non-Communicable Eye Disease Research Capacity in India$233,552
D43 · FY2021 · TW · contact PI
Assessing the Interplay of Vision with Cognitive Functioning, Balance, and Falls in Middle-aged Women$234,000
R21 · FY2020 · EY · contact PI
Glaucoma progression ? Modeling its trajectory and contributing factors: evidence from AGIS and CIGTS$239,202
R21 · FY2019 · EY · contact PI
Assessing the Interplay of Vision with Cognitive Functioning, Balance, and Falls in Middle-aged Women$195,000
R21 · FY2019 · EY · contact PI
Glaucoma progression ? Modeling its trajectory and contributing factors: evidence from AGIS and CIGTS$202,855
R21 · FY2018 · EY · contact PI
Assessing the impact of glaucoma and its treatment on the person$232,500
R21 · FY2016 · EY · contact PI
Assessing the impact of glaucoma and its treatment on the person$193,750
R21 · FY2015 · EY · contact PI
Statins To Prevent Progression of Glaucoma: The STOP Glaucoma Trial$233,250
R34 · FY2013 · EY
Insights on Glaucoma from Analysis of the CIGTS Data$193,125
R21 · FY2012 · EY · contact PI
Insights on Glaucoma from Analysis of the CIGTS Data$233,250
R21 · FY2011 · EY · contact PI
Clinical and Quality of Life Insights on Glaucoma from Analyses of CIGTS Data$193,125
R21 · FY2009 · EY · contact PI
Clinical and Quality of Life Insights on Glaucoma from Analyses of CIGTS Data$231,750
R21 · FY2008 · EY · contact PI
Analysis of CIGTS Visual Field Data$229,500
R03 · FY2005 · EY
Analysis of CIGTS Visual Field Data$229,500
R03 · FY2004 · EY